Clinical Trials Browser

Completed × Intermittent Fasting × 30 days × Clear all

NCT05038137 2026-06-02

TREC

Phase NA Completed

29 enrolled 16 charts

Intermittent Fasting, Breast Neoplasms, Glucose Intolerance